These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 4835598)

  • 21. Allantoxanamide: a potent new uricase inhibitor in vivo.
    Johnson WJ; Chartrand A
    Life Sci; 1978 Nov; 23(22):2239-44. PubMed ID: 723476
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hyperuricemia, gout and gout-induced nephropathy].
    Arkhipov VE; Borisov IA; Nasonov EL; Sura VV
    Ter Arkh; 1980; 52(4):133-42. PubMed ID: 6996182
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic gouty nephropathy: a vanishing syndrome?
    Reif MC; Constantiner A; Levitt MF
    N Engl J Med; 1981 Feb; 304(9):535-6. PubMed ID: 7453785
    [No Abstract]   [Full Text] [Related]  

  • 24. Control of uric acid excretion.
    Steele TH
    N Engl J Med; 1971 May; 284(21):1193-6. PubMed ID: 4929385
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study of uric acid renal elimination in the gout patients and normal patients in spontaneous or experimentally increased or decreased uricemia].
    Prost A; Fontenaille C; Guiheneuc P; Héron B; Lucas J
    Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):33-9. PubMed ID: 4820524
    [No Abstract]   [Full Text] [Related]  

  • 26. Uricase inhibition in the rat by s-triazines: an animal model for hyperuricemia and hyperuricosuria.
    Johnson WJ; Stavric B; Chartrand A
    Proc Soc Exp Biol Med; 1969 May; 131(1):8-12. PubMed ID: 5770131
    [No Abstract]   [Full Text] [Related]  

  • 27. Diminished renal urate secretion per nephron as a basis for primary gout.
    Rieselbach RE; Sorensen LB; Shelp WD; Steele TH
    Ann Intern Med; 1970 Sep; 73(3):359-66. PubMed ID: 4917177
    [No Abstract]   [Full Text] [Related]  

  • 28. [Apparently primary kidney disease revealing latent error of purine metabolism in 2 adolescents].
    Lagrue G; Canlorbe P; Busuttil R
    Ann Pediatr (Paris); 1969 Oct; 16(10):567-72. PubMed ID: 5357395
    [No Abstract]   [Full Text] [Related]  

  • 29. Gout and crystal-related nephropathy.
    Cameron JS; Simmonds HA
    Contrib Nephrol; 1979; 16():147-53. PubMed ID: 467064
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental nephropathy caused by hyperuricemia in rats. Preliminary observations].
    Chériè Lignière G; Carrabba M; Multeni M; Colombo B
    Reumatismo; 1977; 29(2-3):120-4. PubMed ID: 616958
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study on mechanism of urate stone formation. I. Light microscopic study (author's transl)].
    Miyoshi N
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1247-57. PubMed ID: 732060
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of fructose on uric acid metabolism].
    Holländer E
    Acta Med Acad Sci Hung; 1974; 31(3-4):147-55. PubMed ID: 4469712
    [No Abstract]   [Full Text] [Related]  

  • 33. Uric acid crystal-induced nephropathy: evidence for a specific renal lesion in a gouty family.
    Farebrother DA; Pincott JR; Simmons HA; Warren DJ; Dillon MJ; Cameron JS
    J Pathol; 1981 Oct; 135(2):159-68. PubMed ID: 7310574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Uric acid and its metabolism].
    Kissel P; Royer R
    Presse Med (1893); 1968 Dec; 76(49):2317-8. PubMed ID: 5737248
    [No Abstract]   [Full Text] [Related]  

  • 35. [What is certain in gout therapy?].
    Gottesbüren H; Strohmeyer G
    Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physiopathology and treatment of hyperuricemia and gout].
    Louyot P; Pourel J; Gaucher A; Montet Y
    Rein Foie; 1971; 13():103-27. PubMed ID: 5147550
    [No Abstract]   [Full Text] [Related]  

  • 37. [Discussion on the mechanisms of the abscence of renal elimination threshold for uric acid].
    Fontenaille C; Pfluger F; Jozefowicz M; Royer R; Huriet C; Boulangé M
    J Urol Nephrol (Paris); 1971; 77(4):359-64. PubMed ID: 5557145
    [No Abstract]   [Full Text] [Related]  

  • 38. [The kidney and hyperuricemia].
    Lagrue G; Ménard J
    Presse Med (1893); 1971 Apr; 79(19):845-7. PubMed ID: 5576495
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperuricemic nephropathy: pathologic features and factors influencing urate deposition.
    Klinenberg JR; Kippen I; Bluestone R
    Nephron; 1975; 14(1):88-98. PubMed ID: 235747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephropathy and urinary stones in hyperuricemic rats. The effect of aspirin.
    Waisman J; Bluestone R; Klinenberg JR
    Invest Urol; 1977 Jul; 15(1):70-4. PubMed ID: 873740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.